Jackson lab logo

Steve Jackson

Steve Jackson is the Frederick James Quick Professor of Biology in the Department of Biochemistry, School of the Biological Sciences at Cambridge University, UK, and a Senior Group Leader in the Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology in Cambridge. He is Head of Cancer Research UK Laboratories in the Institute. Steve was elected a Fellow of the Royal Society in 2008 and has recently been made BBSRC Innovator of the Year 2009.

Steve is originally from Nottingham in the English Midlands. He obtained his first degree from Leeds University and then did his PhD research with Jean Beggs on yeast RNA splicing, first at the Imperial College of Science and Technology in London and then in the Department of Molecular Biology at Edinburgh University.

After doing post-doctoral research with Robert Tjian at UC Berkeley, CA, USA, where he developed an interest in the regulation of transcription, Steve returned to the UK in 1991 as a Junior Group Leader at the then Wellcome-CRC Institute. Here, he continued his research into transcription by eukaryotic RNA polymerases II and III and expanded this work to include the transcriptional apparatus in Archaea. Through characterising the functions of the DNA-dependent protein kinase, Steve was led into the field of DNA repair and DNA-damage signalling; and for the past eleven years this has been the major focus of his group.

 

In 1997, Steve founded a biotechnology venture, KuDOS Pharmaceuticals Ltd, to transfer research on DNA repair to medical applications. His group maintains strong scientific links with KuDOS, but research in the lab remains independent of the company.

Steve has received several prizes including, Eppendorf European Young Investigator of the Year (1995), the Tenovus Medal (1997), the Biochemical Society Colworth Medal (1997), and the Anthony Dipple Carcinogenesis Young Investigator Award (2002). He is a member of several professional societies and organizations, including the European Molecular Biology Organization (EMBO), the Academy of Medical Sciences and the Fellowship of the Royal Society.

Steve has recently been selected to appear on ISIHighlyCited.com, a free, publicly available website intended to highlight the world's most cited authors from the last two decades.

Steve is the recipient of the Biochemical Society 2008 GlaxoSmithKline Award. The award is made every two years and is intended to recognise distinguished research leading to new advances in medical sciences. Steve received his award at the Biochemical Society's Annual Symposium on "DNA damage: from causes to cures" held at Robinson College, Cambridge in December, 2008. You can watch his award lecture here.

 

Return to top